|
Real-time Estimate
Cboe BZX
13:45:00 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 37.96 USD | +2.25% |
|
-3.21% | - |
| 08-12 | Avalyn Pharma's Q2 Net Loss Widens | MT |
| 08-12 | Earnings Flash (AVLN) Avalyn Pharma Posts Q2 Net Loss $28.9M, vs. FactSet Est of $28.6M Loss | MT |
Chart: Technical Analysis
Stock exchange
Nasdaq
AVLN 38.06 $
+2.50%
1.83M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| AVLN | 38.06USD | +2.50% | 1.83M $ | |
CBOE
| AVLN | 38.13USD | +3.07% | 106K $ |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Neutral |
| Resistance | 39.25 | 39.25 | 39.25 |
| Spread/Res. | -3.21% | -3.21% | -3.21% |
| Spread/Supp. | +15.23% | +47.94% | +40.39% |
| Support | 32.97 | 25.68 | 27.06 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- AVLN Stock
- Charts Avalyn Pharma Inc.
Select your edition
All financial news and data tailored to specific country editions
